サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1320016

タンパク質治療薬市場：タンパク質機能別、製品タイプ別-2023-2030年の世界予測

Protein Therapeutics Market by Protein Function, Product Type - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
タンパク質治療薬市場：タンパク質機能別、製品タイプ別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

タンパク質治療薬の世界市場は、2023年に786億6,000万米ドル、CAGR7.88%で大きく成長し、2030年には1,339億8,000万米ドルという驚異的な規模に達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のタンパク質治療薬市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.タンパク質治療薬の世界市場規模および予測は？

2.予測期間中、世界のタンパク質治療薬市場を形成するCOVID-19の阻害要因と影響は？

3.タンパク質治療薬の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.タンパク質治療薬の世界市場における競争戦略は？

5.タンパク質治療薬の世界市場における技術動向と規制の枠組みは？

6.タンパク質治療薬の世界市場における主要ベンダーの市場シェアは？

7.タンパク質治療薬の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 新興市場におけるヘルスケア支出の増加
      • ヘルスケアサービスを改善するための政府の取り組み
      • 高齢者人口の増加と慢性疾患の優勢性の増加
    • 抑制要因
      • 高い生産コストや組織への浸透効率が低い大きなタンパク質など、タンパク質治療薬の制限
      • 腸内での変性による経口薬としての入手可能性の懸念
    • 機会
      • 二重特異性モノクローナル抗体の可能性
      • 新興諸国における満たされていない医療ニーズ
    • 課題
      • 製造コストと処理コストが高い
      • バイオシミラーとの競合
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 タンパク質治療薬市場タンパク質の機能別

  • 酵素と調節
  • タンパク質診断
  • ワクチン

第7章 タンパク質治療薬市場：製品タイプ別

  • 血液凝固因子
  • エリスロポエチン
  • 卵胞刺激ホルモン
  • G-CSF
  • インスリン
  • インターフェロン
  • モノクローナル抗体

第8章 南北アメリカのタンパク質治療薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のタンパク質治療薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカのタンパク質治療薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. PROTEIN THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. PROTEIN THERAPEUTICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PROTEIN THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2022 VS 2030 (%)
  • FIGURE 5. PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 6. PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. PROTEIN THERAPEUTICS MARKET DYNAMICS
  • FIGURE 8. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. PROTEIN THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PROTEIN THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PROTEIN THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 5. PROTEIN THERAPEUTICS MARKET SIZE, BY ENZYMATIC & REGULATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PROTEIN THERAPEUTICS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. PROTEIN THERAPEUTICS MARKET SIZE, BY BLOOD CLOTTING FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PROTEIN THERAPEUTICS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PROTEIN THERAPEUTICS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PROTEIN THERAPEUTICS MARKET SIZE, BY G-CSF, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. PROTEIN THERAPEUTICS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PROTEIN THERAPEUTICS MARKET SIZE, BY INTERFERONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PROTEIN THERAPEUTICS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PROTEIN FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. PROTEIN THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 103. PROTEIN THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 104. PROTEIN THERAPEUTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-035AB9C0DA42

The Global Protein Therapeutics Market is forecasted to grow significantly, with a projected USD 78.66 billion in 2023 at a CAGR of 7.88% and expected to reach a staggering USD 133.98 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Protein Therapeutics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Protein Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Protein Function, market is studied across Enzymatic & Regulatory, Protein Diagnostics, and Vaccines. The Protein Diagnostics is projected to witness significant market share during forecast period.

Based on Product Type, market is studied across Blood Clotting Factor, Erythropoietin, Follicle Stimulating Hormone, G-CSF, Insulin, Interferons, and Monoclonal Antibodies. The Monoclonal Antibodies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Protein Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Protein Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Protein Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Protein Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Protein Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Protein Therapeutics Market?

6. What is the market share of the leading vendors in the Global Protein Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Protein Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Protein Therapeutics Market, by Protein Function, 2022 vs 2030
  • 4.3. Protein Therapeutics Market, by Product Type, 2022 vs 2030
  • 4.4. Protein Therapeutics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing healthcare expenditure in the emerging markets
      • 5.1.1.2. Government initiatives to improve the healthcare services
      • 5.1.1.3. Growing geriatric population & rising predominance of chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Limitations to protein therapeutics such as high production costs and large proteins with low efficiency to penetrate in tissue
      • 5.1.2.2. Availability concerns as oral drugs due to denaturation in the gut
    • 5.1.3. Opportunities
      • 5.1.3.1. Potential for bispecific monoclonal antibodies
      • 5.1.3.2. Unmet medical needs in developing countries
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of production and treatment
      • 5.1.4.2. Competition from biosimilars
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Protein Therapeutics Market, by Protein Function

  • 6.1. Introduction
  • 6.2. Enzymatic & Regulatory
  • 6.3. Protein Diagnostics
  • 6.4. Vaccines

7. Protein Therapeutics Market, by Product Type

  • 7.1. Introduction
  • 7.2. Blood Clotting Factor
  • 7.3. Erythropoietin
  • 7.4. Follicle Stimulating Hormone
  • 7.5. G-CSF
  • 7.6. Insulin
  • 7.7. Interferons
  • 7.8. Monoclonal Antibodies

8. Americas Protein Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Protein Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Protein Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing